Company Filing History:
3 out of 186 
1 out of 832,843 Years Active: 2019-2023
Title: The Innovative Mind of John Allen Tynan
Introduction
John Allen Tynan, based in San Diego, California, is a prominent inventor with a focus on genetic variations. With a total of four patents to his name, Tynan has made significant contributions to the field of genetic testing, particularly in non-invasive applications.
Latest Patents
Tynan's latest innovations include groundbreaking methods and processes for the assessment of genetic variations. One of his patents addresses non-invasive classification of genetic copy number variations (CNVs) in test samples, proving useful for non-invasive prenatal testing (NIPT) and oncology testing. Another notable patent involves methods for non-invasive assessment of genetic variations, where fetal ploidy is determined using nucleic acid sequence reads from circulating cell-free nucleic acid in the blood of pregnant women. These pioneering technologies reflect Tynan's commitment to advancing genetic testing methodologies.
Career Highlights
Throughout his career, Tynan has worked with various organizations, notably Sequenom, Inc., where he honed his expertise in genetic testing technologies. His contributions have been instrumental in developing reliable and accurate methods for assessing genetic conditions, thereby impacting the landscape of prenatal diagnostics and cancer detection.
Collaborations
Tynan's journey in the field has included collaborations with esteemed individuals such as Grant Hogg and Cosmin Deciu. These partnerships have fostered an environment of innovation, leading to the successful development of transformative technologies in genetics.
Conclusion
John Allen Tynan's work stands as a testament to the power of innovation in the field of genetics. His patents not only reflect his ingenious approach to tackling complex biological challenges but also indicate a promising future for non-invasive genetic testing. As the field progresses, Tynan's contributions will undoubtedly continue to influence how genetic information is assessed and utilized.